T 1151/04 (Effektoren der Dipeptidyl Peptidase IV/Prosidion) of 18.03.2008
- European Case Law Identifier
- ECLI:EP:BA:2008:T115104.20080318
- Date of decision
- 18 March 2008
- Case number
- T 1151/04
- Petition for review of
- -
- Application number
- 97924866.3
- IPC class
- A61K 31/425
- Language of proceedings
- German
- Distribution
- Distributed to board chairmen (C)
- Download
- Decision in German
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Verwendung von aktivitätsmindernden Effektoren der Dipeptidyl Peptidase IV zur Senkung des Blutglukosespiegels in Säugern
- Applicant name
- Prosidion Limited
- Opponent name
- Novartis AG
Bristol-Myers Company
Takeda Chemical Industries, Ltd.
PFIZER LIMITED
BOEHRINGER INGELHEIM PHARMA KG
GLAXO GROUP LIMITED
Novo Nordisk A/S
Mitsubishi Tanabe Pharma Corporation - Board
- 3.3.02
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 100(b) 1973European Patent Convention Art 84 1973
- Keywords
- Ausführbarkeit der Offenbarung (verneint): unzumutbarer Aufwand
- Catchword
- -
- Cited cases
- T 0915/00
ENTSCHEIDUNGSFORMEL
Aus diesen Gründen wird entschieden:
Die Beschwerde wird zurückgewiesen.